Optimizing Treatment Choices for HER2-Mutated Lung Cancer Patients
The landscape of treatment for HER2-mutated non-small cell lung cancer (NSCLC) is evolving rapidly. Recent therapeutic developments, including the swift approval of new therapies, underscore the importance of integrating patient…